Wound-care company Applied Tissue Technologies said it has won FDA clearance of its negative-pressure wound therapy product, the Platform Wound Dressing (PWD). The class II device represents the first-of-its-kind embossed negative pressure wound therapy device to be used without foam or gauze, according to the Hingham, Mass. company. The PWD is a transparent dressing with […]
European scientists develop absorbable bandages
An international research group has developed a biocompatible bandage material that has antibacterial properties and will not require changing, a potential boon for burn patients. The material is self-absorbable, and a new bandage can be put directly on top of the old one, alleviating the need for the frequent and often-painful changing of a burn […]
PolarityTE registers bone repair product with FDA
PolarityTE (NSDQ:PTE) said last week that it registered its bone repair product, OsteoTE, with the FDA. The Utah-based company’s technology is an autologous, homologous product designed to repair, reconstruct and replace bone using a patient’s own cells. Get the full story at our sister site, Drug Delivery Business News.
Acelity’s KCI inks NPWT remote monitoring deal with insurer Highmark
Acelity subsidiary KCI said this week that it inked a negative pressure wound therapy remote monitoring deal, using its iOn Progress remote therapy monitoring program, with health insurer Highmark, touting it as the first such agreement of its kind. The San Antonio-based company’s KCI iOn monitoring program is intended for use with the ACTIV.A.C therapy system, and […]
Will Acelity go public again?
Privately held Acelity may go public again, according to news reports this week. London-based Apax Partners and a pair of Canadian pension funds acquired wound-care company Kinetic Concepts Inc. (now Acelity) for $6.1 billion in a leveraged buyout in 2011. Apax is now mulling an initial public offering for Acelity by mid-2019, Bloomberg and the […]
Skin closure tech dev KitoTech Medical raises $2m
Skin closure device maker KitoTech Medical has raised approximately $1.9 million in a new round of debt and options financing, according to a recently posted SEC filing. The Seattle-based company has developed the MicroMend skin closure device, designed as an alternative to sutures, surgical glue and adhesives trips, according to the company’s website. The MicroMend […]
Smith & Nephew up on Q3 sales gain
Investors pushed share prices for Smith & Nephew (NYSE:SNN) up in London and New York today after the medical device giant posted a third-quarter revenue gain and confirmed its outlook for the rest of the year. The British orthopedics and wound care firm reported that sales grew 1.5% to $1.15 billion during the three months […]
Wound tech dev Clozex Medical raises $4m
Wound closure tech developer Clozex Medical raised approximately $3.8 million in a new round of equity financing, according to a recently posted SEC filing. Funds in the round came from 39 unnamed sources, with the first sale dated on October 16, according to the filing. Wellesley, Mass.-based Clovex is developing wound closure products intended to […]
Acera Surgical raises $5m
Acera Surgical has raised $5.1 million in a new round of equity financing, according to a recently posted SEC filing. The St. Louis-based company is developing an implantable nanomedical scaffold intended for medical applications including soft tissue repair, according to a St. Louis Business Journal report. Acera also produces a protective wound cover called Restrata. […]
Avita launches pediatric burn trial
Avita Medical (ASX:AVH) said today that it launched a new trial of its Recell autologous cell harvesting device exploring its use treating pediatric patients. The Recell autologous cell harvesting device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, the Valencia, Calif.-based company […]
FDA deals warning letter to Ocular over eye sealant
Ocular Therapeutix (NSDQ:OCUL) said today that it received a warning letter from the FDA over its ReSure hydrogel ocular wound sealant. The warning letter, dated Oct. 17, relates to Ocular’s compliance with data collection and reporting obligations in a post-approval device exposure registry study, according to the company. The registry study was a condition for approval […]
- 1
- 2
- 3
- …
- 17
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube